Intermediate filaments attenuate stimulation-dependent mobility of endosomes/lysosomes in astrocytes

Glia. 2010 Aug;58(10):1208-19. doi: 10.1002/glia.21000.

Abstract

Intermediate filament (IF) proteins upregulation is a hallmark of astrocyte activation and reactive gliosis, but its pathophysiological implications remain incompletely understood. A recently reported association between IFs and directional mobility of peptidergic vesicles allows us to hypothesize that IFs affect vesicle dynamics and exocytosis-mediated astrocyte communication with neighboring cells. Here, we ask whether the trafficking of recycling vesicles (i.e., those fused to and then retrieved from the plasma membrane) and endosomes/lysosomes depends on IFs. Recycling vesicles were labeled by antibodies against vesicle glutamate transporter 1 (VGLUT1) and atrial natriuretic peptide (ANP), respectively, and by lysotracker, which labels endosomes/lysosomes. Quantitative fluorescence microscopy was used to monitor the mobility of labeled vesicles in astrocytes, derived from either wild-type (WT) mice or mice deficient in glial fibrillary acidic protein and vimentin (GFAP(-/-)Vim(-/-)), the latter lacking astrocyte IFs. Stimulation with ionomycin or ATP enhanced the mobility of VGLUT1-positive vesicles and reduced the mobility of ANP-positive vesicles in WT astrocytes. In GFAP(-/-)Vim(-/-) astrocytes, both vesicle types responded to stimulation, but the relative increase in mobility of VGLUT1-positive vesicles was more prominent compared with nonstimulated cells, whereas the stimulation-dependent attenuation of ANP-positive vesicles mobility was reduced compared with nonstimulated cells. The mobility of endosomes/lysosomes decreased following stimulation in WT astrocytes. However, in GFAP(-/-)Vim(-/-) astrocytes, a small increase in the mobility of endosomes/lysosomes was observed. These findings show that astrocyte IFs differentially affect the stimulation-dependent mobility of vesicles. We propose that upregulation of IFs in pathologic states may alter the function of astrocytes by deregulating vesicle trafficking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Astrocytes / drug effects
  • Astrocytes / physiology*
  • Atrial Natriuretic Factor / metabolism
  • Biological Transport, Active / drug effects
  • Biological Transport, Active / physiology
  • Cells, Cultured
  • Central Nervous System Agents / pharmacology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiology
  • Endosomes / drug effects
  • Endosomes / physiology*
  • Glial Fibrillary Acidic Protein
  • Intermediate Filaments / drug effects
  • Intermediate Filaments / physiology*
  • Ionomycin / pharmacology
  • Lysosomes / drug effects
  • Lysosomes / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motion
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Rats
  • Rats, Wistar
  • Vesicular Glutamate Transport Protein 1 / metabolism
  • Vimentin / genetics
  • Vimentin / metabolism

Substances

  • Central Nervous System Agents
  • Glial Fibrillary Acidic Protein
  • Nerve Tissue Proteins
  • Slc17a7 protein, mouse
  • Vesicular Glutamate Transport Protein 1
  • Vimentin
  • glial fibrillary astrocytic protein, mouse
  • Ionomycin
  • Atrial Natriuretic Factor
  • Adenosine Triphosphate